Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2017, Article ID 2735296, 5 pages
https://doi.org/10.1155/2017/2735296
Research Article

Forecasting the Incidence and Prevalence of Patients with End-Stage Renal Disease in Malaysia up to the Year 2040

1National Clinical Research Centre, Kuala Lumpur, Malaysia
2Clinical Research Centre, Serdang Hospital, Kajang, Malaysia
3Department of Nephrology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia
4Department of Nephrology, Serdang Hospital, Kajang, Malaysia
5Malaysian Health Performance Unit, Ministry of Health, Kuala Lumpur, Malaysia

Correspondence should be addressed to Mohamad Adam Bujang; ym.vog.crc@mada

Received 6 June 2016; Accepted 22 December 2016; Published 28 February 2017

Academic Editor: Tej Mattoo

Copyright © 2017 Mohamad Adam Bujang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Szczech and I. L. Lazar, “Projecting the United States ESRD population: issues regarding treatment of patients with ESRD,” Kidney International, Supplement, vol. 66, no. 90, pp. S3–S7, 2004. View at Google Scholar · View at Scopus
  2. The National Renal Registry, “22nd Report of the Malaysian Dialysis and Transplant Registry 2014,” 2015.
  3. M. Wakasugi, J. J. Kazama, and I. Narita, “Anticipated increase in the number of patients who require dialysis treatment among the aging population of Japan,” Therapeutic Apheresis and Dialysis, vol. 19, no. 3, pp. 201–206, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Bujang, T. H. Adnan, P. Supramaniam, A. M. Abd Hamid, and J. Haniff, “Prediction number of deaths by occurrence in Malaysia: a comparison between simple linear regression model and holt's linear trend model,” Statistics Malaysia—Journal of the Department of Statistics, Malaysia, vol. 2, pp. 25–37, 2009. View at Google Scholar
  5. L. S. Hooi, T. O. Lim, A. Goh et al., “Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia,” Nephrology, vol. 10, no. 1, pp. 25–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Department of Statistics Malaysia, “Population Quick Info. Department of Statistics,” http://pqi.stats.gov.my/searchBI.php.
  7. M. A. Bujang, A. M. Abdul Hamid, N. A. Zolkepali, N. M. Hamedon, S. S. Mat Lazim, and J. Haniff, “Mortality rates by specific age group and gender in Malaysia: trend of 16 years, 1995–2010,” Journal of Health Informatics in Developing Countries, vol. 6, no. 2, pp. 521–529, 2012. View at Google Scholar
  8. M. A. Bujang, R. Musa, W. J. Liu, T. F. Chew, C. T. S. Lim, and Z. Morad, “Depression, anxiety and stress among patients with dialysis and the association with quality of life,” Asian Journal of Psychiatry, vol. 18, pp. 49–52, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. L. S. Hooi, H. S. Wong, and Z. Morad, “Prevention of renal failure: the Malaysian experience,” Kidney International, Supplement, vol. 67, no. 94, pp. S70–S74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kerr, B. Bray, J. Medcalf, D. J. O'Donoghue, and B. Matthews, “Estimating the financial cost of chronic kidney disease to the NHS in England,” Nephrology Dialysis Transplantation, vol. 27, no. 3, pp. iii73–iii80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. R. Quinn, A. Laupacis, J. E. Hux, R. Moineddin, M. Paterson, and M. J. Oliver, “Forecasting the need for dialysis services in Ontario, Canada to 2011,” Healthcare Policy, vol. 4, no. 4, pp. e151–e161, 2009. View at Google Scholar · View at Scopus
  12. D. Jamison, W. Mosley, and A. Measham, Disease Control Priorities in Developing Countries, World Bank, Washington, DC, USA, 2006.
  13. R. C. Atkins, “The epidemiology of chronic kidney disease,” Kidney International, Supplement, vol. 67, no. 94, pp. S14–S18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Iseki, “Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem,” Journal of Nephrology, vol. 21, no. 3, pp. 305–312, 2008. View at Google Scholar · View at Scopus
  15. R. A. Nugent, S. F. Fathima, A. B. Feigl, and D. Chyung, “The burden of chronic kidney disease on developing nations: a 21st century challenge in global health,” Nephron—Clinical Practice, vol. 118, no. 3, pp. c269–c277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. American Diabetes Association, “Standards of medical care for patients with diabetes mellitus, position Statement. Clinical practice recommendations (2001),” Diabetes Care, vol. 24, pp. S33–S43, 2001. View at Google Scholar
  17. R. H. Grimm Jr., K. H. Svendsen, B. Kasiske, W. F. Keane, and M. M. Wahi, “Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial,” Kidney International. Supplement, vol. 63, pp. S10–S14, 1997. View at Google Scholar · View at Scopus